Literature DB >> 6840476

Antibody to hepatitis B surface antigen in nonprimate animal species.

J H Hoofnagle, D F Schafer, P Ferenci, J G Waggoner, J Vergalla, M April, L Phillips.   

Abstract

The hepatitis B virus infects only humans and higher apes. Viruses similar to the human hepatitis B virus (hepadna viruses) have been discovered in several nonprimate species including woodchucks, ground squirrels, and domesticated ducks. To search for other models of hepatitis B virus infection, we screened serum specimens from 64 exotic animals (24 species), 56 domesticated animals (6 species), and 52 laboratory animals (3 species). Samples were tested for deoxyribonucleic acid polymerase by enzymatic assay and for hepatitis B surface antigen and antibody and antibody to hepatitis B core antigen by radioimmunoassays. All sera were negative for deoxyribonucleic acid polymerase, hepatitis B surface antigen, and antibody to hepatis B core antigen suggesting that none of these animals harbored hepadna viruses in serum. However, 48% of the sera from 58% of the 33 species were reactive for antibody to hepatitis B surface antigen. This reactivity was blocked by human serum positive for hepatitis B surface antigen but not by control human serum. The antibody to hepatitis B surface antigen was generally present in low titer (95% were less than or equal to 1:16) and was often directed against subdeterminants of hepatitis B surface antigen (anti-d, anti-y, or anti-w). Characterization of the antibody to hepatitis B surface antigen by gel chromatography, sucrose density ultracentrifugation, affinity chromatography, and chemical inactivation suggested that it was entirely or predominantly immunoglobulin M antibody. Thus, many animals species have naturally occurring immunoglobulin M antibody to hepatitis B surface antigen detectable by radioimmunoassay. This antibody could arise as a result of either the intermittent spontaneous maturation of clones of antibody to hepatitis B surface antigen forming lymphocytes or exposure to environmental antigens that share epitopes with hepatitis B surface antigen. Similar naturally occurring antibody to hepatitis B surface antigen may be present in some humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840476

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen.

Authors:  E F Robertson; J A Weare; R Randell; P V Holland; G Madsen; R H Decker
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Hepatitis B surface antigen and polymerized albumin binding activity in sheep serum.

Authors:  S G Franklin; I Millman; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  Evaluation of methods of pre-vaccination screening for markers of hepatitis B infection.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; N Tassopoulos; S C Richardson; P Stathopoulou; N Papadoyannakis; N Tsantoulis; K Politi; A Tassiopoulou
Journal:  Eur J Epidemiol       Date:  1985-06       Impact factor: 8.082

Review 4.  Reflections on scrapie and related disorders, with consideration of the possibility of a viral aetiology.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

5.  Seroprevalence of canine hepatitis in stray dogs in Nineveh Province, Iraq.

Authors:  Zahraa Mustafa Al-Jumaa; Eva Aisser Ajaj; Mohammad Osamah Dahl
Journal:  Vet World       Date:  2020-11-04

6.  A novel hepadnavirus in domestic dogs.

Authors:  Georgia Diakoudi; Paolo Capozza; Gianvito Lanave; Francesco Pellegrini; Barbara Di Martino; Gabriella Elia; Nicola Decaro; Michele Camero; Paola Ghergo; Fabio Stasi; Alessandra Cavalli; Maria Tempesta; Vanessa R Barrs; Julia Beatty; Krisztián Bányai; Cristiana Catella; Maria S Lucente; Alessio Buonavoglia; Giovanna Fusco; Vito Martella
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.